Clinical Trial Update: A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age [Phase 2]

View source ↗

Summary

Phase 2 trial comparing immune response and safety of a combined measles, mumps, rubella, and varicella vaccine against a marketed MMRV vaccine in healthy child…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Measles
• Mumps
• Rubella
• Varicella

Drugs mentioned

• Marketed MMRV vaccine (Measles, Mumps, Rubella, Varicella vaccine)
• Priorix-Tetra (Measles, Mumps, Rubella, Varicella vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Measles; Mumps; Rubella; Chickenpox, Measles | Phase 2 | Status: COMPLETED | Results posted: 2025-06-22